Onyx Biotec Peer Comparison

NSE: ONYX

₹42.05

₹0.00 (0.00%)

As on 28-Aug-2026IST

Market cap

₹76 Cr

Revenue (TTM)

₹62 Cr

P/E Ratio

--

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Market cap (₹ Cr)	76	47,610	8,122	1,919	1,100
Revenue (₹ Cr)	62	6,725	7,229	77	287
Net Profit (₹ Cr)	4.95	1,128.79	210.43	16.42	28.67
Net Margin (%)	7.85	16.02	2.88	21.28	9.68
RoE (%)	12.25	11.51	11.02	43.35	9.14
Price to Earnings	--	42.18	38.59	57.37	35.61
Price-To-Book	1.37	4.48	4.06	44.98	4.35

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Operating Revenue	61.95	5,616.50	6,136.05	76.99	239.11
Total Income	63.12	5,830.11	6,184.67	77.13	242.45
Total Expenditure	51.58	4,347.58	5,632.59	51.31	196.46
EBITDA	10.37	1,268.92	503.47	25.68	42.65
Depreciation	3.05	377.87	249.84	0.93	15.02
EBIT	7.33	891.05	253.62	24.76	27.63
Interest	2.02	42.00	118.95	2.94	6.17
Other Income	1.17	213.61	48.62	0.14	3.34
Exceptional Items	--	--	--	--	7.03
Profit before Tax	6.48	1,062.66	183.29	21.95	31.83
Provision for Tax	1.52	364.13	33.06	5.54	6.45
Profit after Tax	4.95	698.53	150.23	16.42	25.38

Liabilities (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Shareholder's Funds	55.62	9,150.74	1,740.56	37.87	208.54
Minority Interest	--	--	-0.66	1.18	0.16
Non-Current Liabilities	9.90	457.27	991.72	12.30	12.82
Current Liabilities	25.73	1,564.85	624.57	26.92	56.70
Total Liabilities	91.25	11,172.85	3,456.02	78.27	284.67

Assets (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Non-Current Assets	42.06	4,389.91	1,464.69	23.71	91.16
Current Assets	49.19	6,782.94	1,891.49	54.55	187.06
Total Assets	91.25	11,172.85	3,456.02	78.27	284.67
Total Debt*	12.46	269.21	0.00	27.39	11.37
Net Current Assets	23.46	5,218.09	1,266.92	27.64	130.35
Contingent Liabilities	--	21.38	13.78	1.58	--

Cashflow (₹ Cr)

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Cash From Operating Activities	1.42	914.73	540.43	-10.47	43.83
Cash Flow from Investing Activities	0.66	1,704.74	-317.61	-22.91	-29.24
Cash from Financing Activities	5.07	-433.48	-227.98	33.23	110.64
Net Cash Inflow / Outflow	7.15	2,185.99	-5.16	-0.14	125.23

Ratios

Profitability Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
ROCE (%)	13.68	11.97	18.22	38.15	24.97
ROE (%)	12.25	7.82	9.21	43.35	21.40
ROA (%)	5.99	6.41	4.73	20.97	12.64
EBIT Margin (%)	18.63	26.40	9.00	33.54	19.23
Net Margin (%)	7.85	11.98	2.43	21.28	10.47
Cash Profit Margin (%)	12.92	19.16	6.43	22.53	16.89

Growth Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Revenue Growth (%)	15.26	-0.85	9.09	0.00	23.53
EBIT Growth (%)	35.55	-1.38	34.23	--	76.27
Net Profit Growth (%)	36.31	-9.57	129.09	0.00	41.44
EPS Growth (%)	0.15	-9.60	129.29	0.00	-35.33
Book Value Growth (%)	119.96	4.91	10.77	0.00	569.07

Valuation Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Price / Earnings	21.23	37.55	60.48	0.00	76.82
Price / Book Value	1.89	2.87	5.30	0.00	11.83
Dividend Yield (%)	0.00	1.13	0.00	--	0.00
EV/EBITDA	9.45	16.15	15.80	1.56	50.94
Market Cap (₹ Cr)	105.17	26,233.01	9,091.18	0.00	2,440.49

Solvency Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debt to Equity	0.22	0.03	0.00	0.72	0.06
Short term debt to equity ratio	0.07	--	--	0.38	--
Current Ratio	1.91	4.33	3.03	2.03	3.30
Quick Ratio	1.29	3.26	0.87	1.54	2.97
Interest Coverage	4.21	26.30	2.54	8.47	6.16

Operating Efficiency Ratios

	Onyx Biotec	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debtors to sales (%)	32.66	27.00	0.22	34.75	15.34
Asset Turnover	0.75	0.52	1.96	0.98	1.19
Receivable days	104.89	99.92	0.90	126.83	47.00
Inventory Days	74.24	108.54	78.76	63.99	33.10
Payable days	142.32	138.65	21.71	39.74	152.61
Cash Conversion Cycle	36.81	69.81	57.95	151.09	-72.51

Annual
Quarterly